Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10047731 | American Journal of Kidney Diseases | 2005 | 4 Pages |
Abstract
The authors report a case of unexplained nephropathy 2 months after ingestion of Herba Aristolochia Mollissemae in a patient with long-standing Crohn's disease and recently diagnosed carcinoma of the colon. It presented as a relentlessly progressing hypocellular interstitial nephritis 5 months after cessation of an earlier course of mesalazine. The patient finally had end-stage renal failure 12 months after taking herbs and required hemodialysis. Aristolochic acid (AA) was detected in the herbal sample of Herba Aristolochia Mollissemae by high-performance liquid chromatography-diode array detection and electrospray ionization-tandem mass spectrometry. Specific AA-DNA adducts were detected in the renal biopsy by 32P-postlabelling analysis. Transitional cell carcinoma was diagnosed 5 months after herb ingestion. It was found that the originally prescribed nonnephrotoxic herb had been substituted by AA-containing Herba Aristolochia Mollissemae at the wholesaler level. Although AA-associated nephropathy could not be proved conclusively, the current case contributed to the withdrawal of the AA-related herbs by the local health authority in Hong Kong. Physicians should be on the alert for herbal nephrotoxicity by possible replacement of nontoxic herbs by nephrotoxic herbs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stanley H. (MRCP), Kin-shing (MRCP), Volker M. PhD, David H. DSc, Chi-kong MSc, Wing-tat MBChB, Ching-kit (MRCP), Ka-leung (MRCP), Kwok-wah (FRCPath), Albert MD,